Raymond de Vre
Chairman chez PolyPeptide Laboratories A/S
Fortune : 554 597 $ au 31/03/2024
Profil
Raymond de Vre is currently the Chairman at PolyPeptide Laboratories A and a Director at Aurigene Discovery Technologies Ltd.
He was previously the Chief Executive Officer at PolyPeptide Group AG from 2021 to 2023 and a Partner at McKinsey & Co., Inc. from 2004 to 2011.
Dr. de Vre holds a doctorate degree from Stanford University and a graduate degree from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,05% | 31/12/2022 | 16 486 ( 0,05% ) | 554 597 $ | 31/03/2024 |
Postes actifs de Raymond de Vre
Sociétés | Poste | Début |
---|---|---|
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Director/Board Member | - |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chairman | - |
Anciens postes connus de Raymond de Vre
Sociétés | Poste | Fin |
---|---|---|
POLYPEPTIDE GROUP AG | Chief Executive Officer | 30/01/2023 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2011 |
Formation de Raymond de Vre
Stanford University | Doctorate Degree |
Université Libre de Bruxelles | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
POLYPEPTIDE GROUP AG | Health Technology |
Entreprise privées | 3 |
---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aurigene Discovery Technologies Ltd.
Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Process Industries |